Jasmine Tea Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-like Behavior in Rats via the Gut-Brain AxisOriginal paper
What was studied?
This study examined whether jasmine tea can ease depressive-like behavior through the brain-gut-microbiome axis. Researchers built a chronic unpredictable mild stress (CUMS) rat model to induce depression-like symptoms and then treated the animals with jasmine tea. They tracked depression-related behavioral indicators alongside changes in the gut microbiota using 16S rRNA sequencing. The goal was to connect microbial shifts to neurochemical changes in the brain.
Who was studied?
The subjects were rats subjected to a chronic unpredictable mild stress protocol designed to produce depressive-like symptoms. The abstract does not report a specific number of animals, strain, sex, or age. This was an animal (rodent) model study rather than a human cohort, and no human population was involved.
What were the most important findings?
Jasmine tea treatment improved depressive-like behaviors and normalized neurotransmitter levels in the CUMS rats. It also increased gut microbiota diversity and richness compared to untreated depressed rats. Spearman correlation analysis linked differential bacterial taxa, including Patescibacteria, Firmicutes, Bacteroidetes, Spirochaetes, Elusimicrobia, and Proteobacteria, to depression-related markers such as BDNF, GLP-1, and 5-HT in the hippocampus and cerebral cortex. The abstract does not mention Desulfovibrio, sulfate-reducing bacteria, hydrogen sulfide, or sulfur metabolism, so this study did not address that angle.
What are the greatest implications of this study?
The findings support the idea that jasmine tea's antidepressant-like effects operate at least partly through modulation of the gut microbiome, not solely through direct brain effects. This strengthens the broader case for the brain-gut-microbiome axis as a target for managing depression. It also suggests dietary or beverage-based interventions could complement other approaches to mood disorders. Because this is a rat model, further work would be needed before drawing conclusions about human depression treatment.